US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 18.230
  • -0.760-4.00%
Trading Mar 26 13:34 ET
620.12MMarket Cap-7.63P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
-8.61M
-16.88M
Net income from continuing operations
-16.09%-80.49M
2.64%-20.63M
-42.80%-20.56M
-1.42%-21.87M
-43.09%-17.42M
-87.86%-69.33M
-102.96%-21.19M
-22.37%-14.4M
---21.57M
---12.17M
Change In working capital
-43.89%7.07M
-40.80%3.53M
366.53%3.35M
-84.16%2.02M
62.34%-1.84M
276.19%12.6M
207.25%5.96M
-172.76%-1.26M
--12.77M
---4.88M
-Change in prepaid assets
-84.86%1.46M
-64.66%1.43M
-86.35%298K
-95.83%246K
79.30%-508K
171.23%9.67M
176.22%4.04M
167.29%2.18M
--5.9M
---2.45M
-Change in payables and accrued expense
91.69%5.63M
9.12%2.11M
188.64%3.06M
-73.84%1.8M
44.71%-1.34M
-54.23%2.94M
850.97%1.93M
-169.45%-3.45M
--6.87M
---2.42M
-Change in other current assets
42.86%-20K
97.14%-1K
--0
-157.14%-18K
66.67%-1K
-318.75%-35K
-3,600.00%-35K
150.00%10K
---7K
---3K
-Change in other current liabilities
-108.00%-2K
-116.00%-4K
---4K
---4K
--10K
--25K
--25K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
Investing cash flow
Cash flow from continuing investing activities
-192.47M
-869.86%-192.47M
0
0
25M
0
Net investment purchase and sale
---192.47M
-869.86%-192.47M
--0
----
----
--0
--25M
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---192.47M
-869.86%-192.47M
--0
----
----
--0
--25M
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
335.34%186.58M
105.20%55K
151.40%531K
1,915.00%363K
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
-1.03M
-20K
44.97M
Net common stock issuance
--185.95M
--0
--0
--319K
--185.63M
--0
--0
--0
--0
--0
Net preferred stock issuance
--0
--0
--0
--0
--0
-73.53%44.92M
--0
--0
---24K
--44.94M
Proceeds from stock option exercised by employees
78.25%631K
-80.70%55K
1,261.54%531K
1,000.00%44K
-96.15%1K
2,260.00%354K
1,800.00%285K
--39K
--4K
--26K
Net other financing activities
----
----
----
----
----
---2.41M
---1.34M
----
----
----
Cash from discontinued financing activities
Financing cash flow
335.34%186.58M
105.20%55K
151.40%531K
1,915.00%363K
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
---1.03M
---20K
--44.97M
Net cash flow
Beginning cash position
-7.95%150.39M
100.10%282.86M
89.23%298.67M
65.78%317.39M
-7.95%150.39M
338.23%163.37M
103.28%141.36M
98.62%157.83M
--191.46M
--163.37M
Current changes in cash
-486.12%-76.1M
-2,409.66%-208.56M
4.01%-15.81M
44.32%-18.72M
494.57%167M
-110.30%-12.98M
-90.38%9.03M
-65.98%-16.48M
---33.63M
--28.09M
End cash Position
-50.60%74.29M
-50.60%74.29M
100.10%282.86M
89.23%298.67M
65.78%317.39M
-7.95%150.39M
-7.95%150.39M
103.28%141.36M
--157.83M
--191.46M
Free cash flow
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M-8.61M-16.88M
Net income from continuing operations -16.09%-80.49M2.64%-20.63M-42.80%-20.56M-1.42%-21.87M-43.09%-17.42M-87.86%-69.33M-102.96%-21.19M-22.37%-14.4M---21.57M---12.17M
Change In working capital -43.89%7.07M-40.80%3.53M366.53%3.35M-84.16%2.02M62.34%-1.84M276.19%12.6M207.25%5.96M-172.76%-1.26M--12.77M---4.88M
-Change in prepaid assets -84.86%1.46M-64.66%1.43M-86.35%298K-95.83%246K79.30%-508K171.23%9.67M176.22%4.04M167.29%2.18M--5.9M---2.45M
-Change in payables and accrued expense 91.69%5.63M9.12%2.11M188.64%3.06M-73.84%1.8M44.71%-1.34M-54.23%2.94M850.97%1.93M-169.45%-3.45M--6.87M---2.42M
-Change in other current assets 42.86%-20K97.14%-1K--0-157.14%-18K66.67%-1K-318.75%-35K-3,600.00%-35K150.00%10K---7K---3K
-Change in other current liabilities -108.00%-2K-116.00%-4K---4K---4K--10K--25K--25K--0--0--0
Cash from discontinued investing activities
Operating cash flow -25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M
Investing cash flow
Cash flow from continuing investing activities -192.47M-869.86%-192.47M0025M0
Net investment purchase and sale ---192.47M-869.86%-192.47M--0----------0--25M--0--------
Cash from discontinued investing activities
Investing cash flow ---192.47M-869.86%-192.47M--0----------0--25M--0--------
Financing cash flow
Cash flow from continuing financing activities 335.34%186.58M105.20%55K151.40%531K1,915.00%363K312.80%185.63M-74.75%42.86M-100.96%-1.06M-1.03M-20K44.97M
Net common stock issuance --185.95M--0--0--319K--185.63M--0--0--0--0--0
Net preferred stock issuance --0--0--0--0--0-73.53%44.92M--0--0---24K--44.94M
Proceeds from stock option exercised by employees 78.25%631K-80.70%55K1,261.54%531K1,000.00%44K-96.15%1K2,260.00%354K1,800.00%285K--39K--4K--26K
Net other financing activities -----------------------2.41M---1.34M------------
Cash from discontinued financing activities
Financing cash flow 335.34%186.58M105.20%55K151.40%531K1,915.00%363K312.80%185.63M-74.75%42.86M-100.96%-1.06M---1.03M---20K--44.97M
Net cash flow
Beginning cash position -7.95%150.39M100.10%282.86M89.23%298.67M65.78%317.39M-7.95%150.39M338.23%163.37M103.28%141.36M98.62%157.83M--191.46M--163.37M
Current changes in cash -486.12%-76.1M-2,409.66%-208.56M4.01%-15.81M44.32%-18.72M494.57%167M-110.30%-12.98M-90.38%9.03M-65.98%-16.48M---33.63M--28.09M
End cash Position -50.60%74.29M-50.60%74.29M100.10%282.86M89.23%298.67M65.78%317.39M-7.95%150.39M-7.95%150.39M103.28%141.36M--157.83M--191.46M
Free cash flow -25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+0.73%
Petroleo Brasileiro SA Petrobras
PBR
+0.43%
KB Home
KBH
+0.15%
Vale SA
VALE
-0.15%
Taylor Morrison Home
TMHC
-0.62%

Unlock the Full List